JPS52142015A - Therapeutic product for split personality - Google Patents

Therapeutic product for split personality

Info

Publication number
JPS52142015A
JPS52142015A JP3203477A JP3203477A JPS52142015A JP S52142015 A JPS52142015 A JP S52142015A JP 3203477 A JP3203477 A JP 3203477A JP 3203477 A JP3203477 A JP 3203477A JP S52142015 A JPS52142015 A JP S52142015A
Authority
JP
Japan
Prior art keywords
therapeutic product
split personality
personality
split
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3203477A
Other languages
Japanese (ja)
Inventor
Edowaado Furooman Chiyaarusu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MISHIGANSHIYUU
Original Assignee
MISHIGANSHIYUU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/772,851 external-priority patent/US4146614A/en
Application filed by MISHIGANSHIYUU filed Critical MISHIGANSHIYUU
Publication of JPS52142015A publication Critical patent/JPS52142015A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0804Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1016Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP3203477A 1976-03-23 1977-03-23 Therapeutic product for split personality Pending JPS52142015A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66952676A 1976-03-23 1976-03-23
US05/772,851 US4146614A (en) 1976-03-23 1977-02-28 Threonyl-valyline leucine containing peptides and pharmaceutical compositions

Publications (1)

Publication Number Publication Date
JPS52142015A true JPS52142015A (en) 1977-11-26

Family

ID=27100128

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3203477A Pending JPS52142015A (en) 1976-03-23 1977-03-23 Therapeutic product for split personality

Country Status (13)

Country Link
JP (1) JPS52142015A (en)
AU (1) AU510679B2 (en)
CA (1) CA1103239A (en)
DE (1) DE2712781A1 (en)
DK (1) DK125177A (en)
FR (1) FR2351954A1 (en)
GB (1) GB1561247A (en)
GR (1) GR63642B (en)
LU (1) LU76998A1 (en)
NL (1) NL7703124A (en)
NO (1) NO771031L (en)
NZ (1) NZ183627A (en)
SE (1) SE7702925L (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ214543A (en) * 1984-12-14 1990-03-27 Australian Commercial Research Amino acid and peptide derivatives that inhibit human leucocytic elastase enzyme (hle)
JPH03236315A (en) * 1989-12-05 1991-10-22 Nippon Oil & Fats Co Ltd Antipsychotic agent

Also Published As

Publication number Publication date
AU510679B2 (en) 1980-07-10
CA1103239A (en) 1981-06-16
DE2712781A1 (en) 1977-10-06
GR63642B (en) 1979-11-27
AU2317477A (en) 1978-09-14
NO771031L (en) 1977-09-26
NL7703124A (en) 1977-09-27
FR2351954A1 (en) 1977-12-16
LU76998A1 (en) 1977-10-03
GB1561247A (en) 1980-02-13
SE7702925L (en) 1977-09-24
DK125177A (en) 1977-09-24
NZ183627A (en) 1980-02-21
FR2351954B1 (en) 1980-03-28

Similar Documents

Publication Publication Date Title
JPS51141092A (en) Skin package
PT67121A (en) Product
AU1495476A (en) Netlike product
JPS5323957A (en) Cyclohexane derivatives
IL48649A (en) Split cable-sleeves
JPS51128489A (en) Enzyme product
JPS51142520A (en) Controlled liberation product
AU1888276A (en) Catalysts
JPS55159777A (en) Packaged product
AU514726B2 (en) Mycofungicidal product
GB2005591B (en) Product
JPS52128357A (en) Antiitumor drug
AU502360B2 (en) Methsnstion catalyst
JPS52142015A (en) Therapeutic product for split personality
AU503590B2 (en) Mould
JPS52114010A (en) Medicine for nicotinism
AU500742B2 (en) Catalyst
JPS527421A (en) Eyewash
JPS5223078A (en) Cyclohexanol derivatives
JPS5338620A (en) Isomalin antiimold drug
JPS5186417A (en) Ketonmerukaputaaru ss okishidooseizosuruhoho
AU500853B2 (en) Diphenyl ether amides
AU497367B2 (en) Catalyst
AU1548676A (en) Catalyst
AU499149B2 (en) Quasi-vitreous fat